Comet Bio Denmark ApS: Financial statements 2024
CVR: 43297333
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Comet Bio Denmark ApS (CVR 43297333) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 52,167,471 and a net result of DKK 51,637,070 compared with DKK -65,764,641 the year before. Equity in the 2024 report amounted to DKK -18,120,555. The company had 1 employee in the financial year.
- Gross Profit
- DKK 52,167,471
- Profit/Loss
- DKK 51,637,070
- Equity
- DKK -18,120,555
- Total Assets
- DKK 15,735,591
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 52.2 mio. | 51.6 mio. | -18.1 mio. | 1 |
| 2023 | - | -50.7 mio. | -65.8 mio. | -69.8 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Comet Bio Denmark ApS has published its annual report for 2023. Gross profit came to DKK -50,706,731, and the net result was DKK -65,764,641.
As of April 1, 2024, Loula Sassaris Merkel is registered as adm. dir. of Comet Bio Denmark ApS.
As of March 17, 2024, Stephen Jonathan Jones has stepped down as director of Comet Bio Denmark ApS.
About Comet Bio Denmark ApS
Comet Bio Denmark ApS is a Danish company of the type Anpartsselskab based in Kalundborg, founded in 2022. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Loula Sassaris Merkel. The company is owned by Comet Biorefining Inc.. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 3,693 and a net result of DKK -161,466 compared with DKK 51,637,070 the year before. Equity in the 2025 report amounted to DKK -18,282,021.